VEGFA and neoplasm: Endostar can inhibit tumor growth primarily through direct inhibition of vascular endothelial cell proliferation via multiple targets such as vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor-2 (VEGFR-2) and platelet-derived growth factor receptor (PDGFR).